Showing 81 - 100 results of 743 for search '"chronic kidney disease"', query time: 0.11s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84

    Hypertension, Chronic Kidney Disease, and Renal Pathology in a Child with Hermansky-Pudlak Syndrome by Roberto Gordillo, Marcela Del Rio, David B. Thomas, Joseph T. Flynn, Robert P. Woroniecki

    Published 2011-01-01
    “…We report a child with Hermansky-Pudlak Syndrome (HPS) and chronic kidney disease (stage II) with histological diagnosis of focal segmental glomerulosclerosis (FSGS). …”
    Get full text
    Article
  5. 85
  6. 86
  7. 87

    Urinary concentrations of arsenic species in older Dutch adults and risk of chronic kidney disease by Hannah P. McKeon, Weiluan Chen, Jan Dirk te Biesebeek, Nanette G. Vrijenhoek, Jacqueline J.M. Castenmiller, Marcel J.B. Mengelers

    Published 2025-02-01
    “…To assess the risk of internal As exposure, toxic relevant arsenic (TRA) (sum of arsenite (As(III)), arsenate (As(V)), and their methylation metabolites, monomethylarsonate (MMA) and dimethylarsinate (DMA)) in urine should be used.Morning urine samples of 288 Dutch adults (aged 52–91 years) were analysed for As(III), As(V), MMA, DMA, arsenobetaine (AsB) and total As using ICP-MS. The risk of chronic kidney disease (CKD) related to TRA exposure in participants was assessed. …”
    Get full text
    Article
  8. 88
  9. 89
  10. 90

    mHealth education for patients with chronic kidney disease: protocol for a scoping review by Anders Nikolai Ørsted Schultz, Kristian Kidholm, Jan Dominik Kampmann, Caroline Moos, Eithne Hayes Bauer

    Published 2022-07-01
    “…Introduction More than 10% of the population worldwide is affected by chronic kidney disease (CKD). Despite many promising indications regarding the use of mHealth education for patients with CKD, there is still little evidence regarding the feasibility, effectiveness outcomes and outcome measures. …”
    Get full text
    Article
  11. 91

    Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia by Zhimin Liao, Lei Xu, Bo Wan, Liping Wang, Chengzhi Zhao, Gang Wu, Rui Xie

    Published 2022-01-01
    “…To compare the efficacy of febuxostat and allopurinol in the treatment of chronic kidney disease (CKD) at stages 3∼5 with hyperuricemia. …”
    Get full text
    Article
  12. 92
  13. 93
  14. 94

    High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease by Maria Vittoria Arcidiacono, Montserrat Martinez-Alonso, Montserrat Belart, Ana Vilar, Marisa Martín, Lourdes Craver, Àngels Betriu, Dídac Mauricio, José Manuel Valdivielso, Elvira Fernández, Mercè Borràs

    Published 2017-01-01
    “…Chronic kidney disease (CKD) patients, characterized by traditional and nontraditional risk factors, are prone to develop atheromatosis and thus cardiovascular events and mortality. …”
    Get full text
    Article
  15. 95

    Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad by Mário Raimundo, José António Lopes

    Published 2011-01-01
    “…The metabolic syndrome (MS) and chronic kidney disease (CKD) have both become global public health problems, with increasing social and economic impact due to their high prevalence and remarkable impact on morbidity and mortality. …”
    Get full text
    Article
  16. 96
  17. 97

    The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol. by Claire Carswell, Kate Bramham, Joseph Chilcot, Rowena Jacobs, David Osborn, Najma Siddiqi

    Published 2025-01-01
    “…This contributes to an inequality in life expectancy known as the 'mortality gap'. Chronic kidney disease (CKD) is a growing global health concern set to be the 5th leading cause of life-years lost by 2040. …”
    Get full text
    Article
  18. 98

    Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study by Ming-Ju Wu, Chew-Teng Kor, Chia-Chu Chang, Shuo-Chun Weng, Chia-Lin Wu, Ping-Fang Chiu, Der-Cherng Tarng

    Published 2017-12-01
    “…Objective We compared the incidence and risk of chronic kidney disease (CKD) between subjects with new-onset migraine and matched controls without migraine in this large-scale retrospective cohort study.Design Population-based cohort study.Setting 8880 subjects with migraine and 503 070 subjects without migraine were enrolled between January 1, 2000 and December 31, 2013, all diagnosed to be without kidney disease. …”
    Get full text
    Article
  19. 99

    Urinary Proteomic Shifts over Time and Their Associations with eGFR Decline in Chronic Kidney Disease by Zhalaliddin Makhammajanov, Kamila Nurlybayeva, Zikrillo Artikov, Pavel Tarlykov, Mohamad Aljofan, Rostislav Bukasov, Duman Turebekov, Syed Hani Abidi, Mehmet Kanbay, Abduzhappar Gaipov

    Published 2025-01-01
    “…Chronic kidney disease (CKD) is a progressive condition characterized by declining renal function, with limited biomarkers to predict its progression. …”
    Get full text
    Article
  20. 100

    Effects of Resistant Starch on Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis by Xinyi Du, Jing Wu, Chenlin Gao, Qinqin Tan, Yong Xu

    Published 2022-01-01
    “…Background. Chronic kidney disease (CKD) is a main health problem associated with increased risk of cardiovascular disease, morbidity, and mortality. …”
    Get full text
    Article